aluminum clofibrate
- 中文别名：对氯苯氧异丁酸
- 中文释义：对氯苯氧异丁酸;2-(4-氯苯氧基)-2-甲基丙酸
- 英文别名：Aluminium hydroxide 2-(4-chlorophenoxy)-2-methylpropanoate (1:1:2 );
Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, aluminum salt, hydrate (2:1:1);
2-(4-Chlorophenoxy)-2-methylpropanoic acid-aluminium hydrate (2:1:1);
Aluminum Clofibrate;
Aluminium clofibrate;
Aluminum hydroxide 2-(4-chlorophenoxy)-2-methylpropanoate (1:1:2);
3,3'-[propane-1,2-diylbis(oxy)]dipropan-1-ol;
tripropylene glycol, mixture of isomers;
Tripropylene glycol;
3,7-dimethyloct-6-en-1-yl (2E)-2-methylbut-2-enoate;
3,7-dimethyloct-6-enyl (E)-2-methylbut-2-enoate;
Citronellyl tiglate;
Photoinitiator 651;
2,2-Dimethoxy-2-phenylacetophenone;
P-Dhp;
Pregn-4-ene-3,20-dione, 16,17-((1-phenylethylidene)bis(oxy))-, (16alpha(R))-;
SQ 15101;
UNII-OL7KC2O3OT;
(R)-16alpha,17-((1-Phenylethylidene)dioxy)pregn-4-ene-3,20-dione;
Pregn-4-ene-3,20-dione, 16-alpha,17-dihydroxy-, cyclic acetal with acetophenone, (R)-;
(4bS,6bS,9aR,10aS)-6b-acetyl-4a,6a,8-trimethyl-8-phenyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one;
(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bR)-6b-acetyl-4a,6a,8-trimethyl-8-phen
- CAS No.：24818-79-9
- 分子式：C20H21AlCl2O7
- 分子量：0
- 精确分子量：473.07100
- PSA：121.78000
- 分子结构式：
物化性质
- 熔点：
- 120-123ºC
- 沸点：
- 324.1ºC at 760mmHg
- 闪点：
- 149.8ºC
安全信息
- 熔点：
- 120-123ºC
- 沸点：
- 324.1ºC at 760mmHg
- 闪点：
- 149.8ºC
毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- BD0348000
- CHEMICAL NAME :
- Aluminum, bis(2-(4-chlorophenoxy-kappaO)-2-methylpropanoateo-ka ppaO)hydroxy-
- CAS REGISTRY NUMBER :
- 24818-79-9
- LAST UPDATED :
- 199803
- DATA ITEMS CITED :
- 9
- MOLECULAR FORMULA :
- C20-H21-Al-Cl2-O7
- MOLECULAR WEIGHT :
- 471.29
- WISWESSER LINE NOTATION :
- OVX1&1&OR DG 2 &.AL-Q
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >10 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,237,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3300 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JJPAAZ Japanese Journal of Pharmacology. (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951- Volume(issue)/page/year: 23,281,1973
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 5100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,237,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >10 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,237,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 3300 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,237,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 5850 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,237,1982 ** OTHER MULTIPLE DOSE TOXICITY DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 24 gm/kg/12D-I
- TOXIC EFFECTS :
- Liver - changes in liver weight Endocrine - changes in spleen weight Related to Chronic Data - death
- REFERENCE :
- KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 5,749,1971
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 24 gm/kg/12D-I
- TOXIC EFFECTS :
- Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Endocrine - changes in spleen weight
- REFERENCE :
- KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 5,749,1971 ** REPRODUCTIVE DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 6 gm/kg
- SEX/DURATION :
- female 7-12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - other effects Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- REFERENCE :
- KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 5,749,1971
热门化工词典词汇
- 2(3H)-Thiazolethione,3-[[(4-methylphenyl)methylene]amino]-4-phenyl-非扎硫酮
- 8-aminoquinolin-2(1H)-one8-氨基-2(1H)-喹啉酮
- 1H-Azuleno[5',6':3,4]benz[1,2-b]oxete-4,5,6,8,10,10b(2aH)-hexol,3,4,4a,5,6,8,9,9a,10,10a-decahydro-9a-(1-hydroxy-1-methyl1H-薁并[5',6':3,4]苯并[1,2-b]噁丁-4,5,6,8,10,10b(2aH)-六唑,3,4,4a,5,6,8,9,9a,10,10a-十氢-9a-(1-羟基-1-甲基乙基)-4a,7-二甲基-,4,10,10b-三乙酸酯 5-苯酸酯, (2aR,4S,4aS,5R,6R,8S,9aS,10S,10aR,10bS)-
- 1H-Pyrazolo[4,3-b]pyridine, 7-broMo-7-溴-1H-吡唑并[4,3-b]吡啶
- 2,7-Naphthalenedisulfonicacid,5-[[4-[bis[2-[(2-chloroethyl)sulfonyl]ethyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-4-hyd5-[[4-[二[2-[(2-氯乙基)磺酰基]乙基]氨基]-6-氯-1,3,5-三嗪-2-基]氨基]-4-羟基-3-[(2-磺基苯基)偶氮]-2,7-萘二磺酸
- 6-iodo-1-methoxynaphthalene{[(4-氯苯亚甲基)氨基]氧代}(甲基氨基)甲酮
- 8-Methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine hydrochlo ride (1:1)8-甲氧基-n-丙基-2-氨基四氢化萘盐酸盐
- 4-Isoxazolecarboxylic acid, 5-[(butylamino)carbonyl]-3-[[(2,5-dimethylphenyl)thio]methyl]-5-[(丁基氨基)羰基]-3-[[(2,5-二甲基苯基)硫代]甲基]-4-异恶唑羧酸
- 4-[2-(Chloromethyl)benzimidazol-1-yl]butyl Pivalate4-[2-(氯甲基)苯并咪唑-1-基]丁基新戊酸酯
- b-D-Glucopyranoside, 2-nitrophenyl2-(acetylamino)-2-deoxy-2-硝基苯基-2-乙酰氨基-2-脱氧-beta-D-吡喃葡萄糖苷
